Following the short-term negative impact of the COVID-19 pandemic on the Asia Pacific PV device market, the high prevalence of PAD in the region, an expanding patient population, growth in…
The COVID-19 pandemic had a negative impact on the European PV device market in 2020, and to some extent in 2021 and 2022. Following the impact of the pandemic, increasing physician awareness of…
Following the short-term negative impact of the COVID-19 pandemic on the Asia Pacific peripheral vascular device market, the high prevalence of PAD in the region, an expanding patient population,…
While the COVID-19 pandemic will have a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price…
Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV…
While the COVID-19 pandemic will have a negative impact on the Latin American peripheral vascular device market in the short term, a large undiagnosed patient population, rising PVD diagnosis rates…
While the COVID-19 pandemic has had a negative impact on the European peripheral vascular device market in the short term, the dynamic nature of the PV market, the launch of novel premium-price…
A large undiagnosed patient population, rising PVD diagnosis rates, and growth in endovascular procedure volumes will support continued growth in the Latin American PV device market; however, cost…
The Canadian market for PV devices is an evolving market in which an underdiagnosed and underserved patient population and innovative product launches will facilitate significant procedure…